The Leibniz-Institut für Molekulare Pharmakologie in Berlin is using Tecan's Freedom EVO workstations for systematic high-throughput screening of bioactive small molecule libraries. Peter von Kries, head of the Institute's screening unit, explained: “The unit has a small team of staff performing library screens of around 20,000 compounds a day, and this high throughput is partly thanks to the flexibility of our Freedom EVO workstations.
Many of our projects use either high-content screening with automated microscopes or genome-wide RNA interference (RNAi) studies, and we have a Freedom EVO system configured for each of these methods.
“Each workstation has been collaboratively designed with the Tecan Integration Group (TIG) to create a robust system capable of high-throughput analysis, giving consistent results even over long-term use. The approval procedure is central to this process, with factory and site acceptance tests to guarantee that the platform matches our needs exactly. Tecan has an exceptional culture of customer service, and our work here at the FMP undoubtedly benefits from this close partnership."
www.tecan.com/freedomevo